Andrew J. Hirsch

Andrew J. Hirsch

DirectoratC4 Therapeutics· In proxies 2022–2025

Pay in FY2025-44% from the year before · C4 Therapeutics stock -46.9% the same year

Andrew J. Hirsch was paid $2.9M in FY2025 (Dec), down 44%. C4 Therapeutics stock fell 46.9% that year.

Pay$100 in the stock at the end of FY21 → $6
Pay is from the Summary Compensation Table of each C4 Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Editas MedicinePublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  2. C4 TherapeuticsPublic company · 4 yr
    • President & Chief Executive Officer2022 – Present · 4 yrStock in role -90%
  3. Akamis Bio, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • Editas MedicineDirector · 8 yr on the boardIndependentAudit (Chair), Compensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?